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A B S T R A C T
Objective: This study aimed to increase our understanding of general self-management (SM) abilities in
COPD by determining if SM can predict disease speciﬁc quality of life (QoL), by investigating whether
speciﬁc SM domains are signiﬁcant in COPD and by exploring the mediating effect of the positive/
negative affect in the association between SM and QoL.
Methods: Cross-sectional study based on 292 patients with COPD. Measures included demographics, lung
function, gait speed, health care utilization, positive/negative affect, SM abilities, breathlessness and
disease speciﬁc QoL. We performed, correlation, multiple regression models and mediation analysis
(positive/negative affect being mediator between SM and QoL association).
Results: After controlling for breathlessness, living alone, marital status, hospitalization history, age and
lung function, SM related to QoL (p < 0.0001). Investment in behaviors (hobbies and social relationships)
and self-efﬁcacy are SM domains independently related to QoL in COPD. Positivity measured by the
positive/negative affect ratio completely mediates the relationship of SM with QoL.
Conclusion: SM is independently associated with disease speciﬁc QoL in COPD after adjustment
signiﬁcant covariates but positive/negative affect ratio completely mediates the relationship of SM with
QoL.
Practice implications: Measuring positive/negative affect and addressing investment behavior and self-
efﬁcacy are important in implementing COPD-SM programs.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Chronic obstructive pulmonary disease (COPD) is one of the
main causes of morbidity and mortality worldwide and is expected
to become the third cause of death and the ﬁfth cause of disability-
adjusted life years in 2020 [1]. International guidelines for
managing COPD posit self-management (SM) programs as a
critical part of COPD treatment [2]. Patient’s SM support, is a
recognized component of the Chronic Care Model [3], and has
received increasing attention in recent years in the ﬁeld of COPD
due to its impact on critically important outcomes such as disease
speciﬁc quality of life (QoL) and hospitalizations [4]. SM is
particularly important in patients with COPD as they experience
greater physical health losses and are dealing with greater
depressive symptoms compared to patients with diabetes and* Corresponding author at: Mindful Breathing Lab, Division of Pulmonary &
Critical Care,Mayo Clinic, 200 First Street SW, Gonda 18-440, Rochester, MN 55902,
USA. Fax: +507 266 4372.
E-mail address: benzo.roberto@mayo.edu (R.P. Benzo).
http://dx.doi.org/10.1016/j.pec.2015.10.031
0738-3991/ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access a
nd/4.0/).cardiovascular disease [5]. COPD-SM is most commonly associated
with the use of written action plans for early signs of COPD
exacerbations with differing results [6,7]. However, SM goes far
beyond prescription of written plans for exacerbations. Recent data
suggest that the effectiveness of SM programs may be limited if
they are not incorporated in a more extensive individualized
assessment of the whole patient that goes beyond the speciﬁcities
of disease, COPD in this case [4].
There is a knowledge gap relating to SM abilities in COPD
patients beyond the use of a written action plan for exacerbations
and the association of those abilities with QoL, a critical outcome in
COPD [1]. In particular, little is known about the speciﬁc aspects of
SM that are independently associated with improved QoL in COPD,
with the goal of incorporating them into COPD SM or care
programs.
Validated tools to comprehensively measure SM are not
commonly used in COPD SM research. The Self-Management
Ability Scale 30 (SMAS-30) is a tool to measure general SM in
chronic disease that has been reported as a valid and reliable tool to
comprehensively measure SM [5,8–11]. The tool measures abilities
needed to achieve maintain or restore aspects of physical andrticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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SMAS-30 with well-being in COPD patients, there is no report to-
date in the literature about the association of this measure with the
most critical outcomes in COPD, such as QoL, frailty measures (gait
speed), hospitalizations, lung function, breathlessness level that
can further inform the relevance of using SMAS-30 in COPD SM
research.
Another important aspect to consider at the time of imple-
menting SM support programs is to know which factors moderate
or mediate the effect of SM abilities on wellbeing (QoL). Given the
importance of positive and negative affect in COPD, it is plausible to
believe that they can at least moderate or even mediate the effect
of SM support [12,13]. Positive affect has been shown to inﬂuence
health in multiple ways [14]. Positive affect interventions have had
marked effects on people’s cognitive processes, social behavior,
motivation, self-efﬁcacy (which is at the very core of SM), and
ability to cope with stressful life events. Individuals with positive
affect have felt more intrinsically motivated and were more able to
try new things [15,16], both conditions that may be associated with
the effect of SM support interventions. We hypothesize that the
degree of positive/negative affect (clinical positivity ratio) may
moderate or at most mediate the associations of SM with other
meaningful outcomes in COPD (Fig. 1).
The purpose of this cross-sectional cohort study was to test the
following aims:
First, determine the association of SMAS-30 with the most
important outcomes in COPD. Second, to establish if there is a
signiﬁcant and independent association between SM abilities and
disease speciﬁc QoL, measured by the chronic respiratory
questionnaire, a cardinal outcome in COPD. Third, identify which
aspects of SM, as deﬁned by the SMAS-30 subdomains, are
independently associated with disease speciﬁc QoL. Finally, if a
signiﬁcant association is found between SM and QoL, investigate if
the association is mediated by positive affect, as proposed in
previous research in other chronic diseases [17]. We envisioned
that the results of this study could be seminal to craft
comprehensive SM interventions in COPD patients.
2. Methods
292 patients with COPD were prospectively recruited from the
Pulmonary Clinic at Mayo Clinic, Rochester, MN (USA). The
following inclusion criteria were used: diagnosis of COPD based
on the Global Initiative for COPD 2011 guidelines [1] age >40 years
old, history of smoking more than 10 packs-year and able to
complete questionnaires. This study received the Mayo Clinic
Institutional Review Board approval (IRB number: 13-004603) and
all patients signed research consent. Investigators recorded, at the
moment of the recruitment, demographics, health care utilization
and pulmonary function information.
2.1. General survey
The general survey contains four items addressing the
following: [1] the patient’s smoking status, [2] frequency of lung
disease exacerbations, [3] frequency of hospitalizations forFig. 1. Theoreticarespiratory and non-respiratory issues and [4] frequency of ER/
Urgent Care visits for respiratory and non-respiratory causes. Data
regarding living situation (living alone or not), marital status, use
of permanent oxygen, co-morbidities, and activities of daily living
were also obtained from the medical record as it is part of the
current visit questionnaire used for all patients at Mayo Clinic.
2.2. Pulmonary function testing
All patients included in the study had Pulmonary Function Tests
completed in the outpatient Pulmonary Function Laboratory at
Mayo Clinic, Rochester, MN (USA). The severity of the airﬂow
limitation was classiﬁed based on the GOLD criteria [1]. The Global
Obstructive Lung Disease Initiative (GOLD) categorize COPD based
on the degree lung obstruction in stages: Stage 1 COPD is
considered mild and has few symptoms. Coughing is infrequent.
Lung function tests reveal forced expiratory volume (FEV1), the
measure of bronchial obstruction numbers at less than 80 percent
of normal. Stage 2 COPD is considered moderate. Shortness of
breath while exercising is common. Patients with moderate COPD
beneﬁt from self-management, health coaching and exercise. Stage
2 FEV1 numbers reﬂect between 50 and 79 percent of normal lung
function. Stage 3 COPD patients have increased shortness of breath.
Lung function tests show between 30 and 49 percent of normal
function. Stage 4 COPD reﬂects severe lung damage. Symptoms
worsen, and coughing and mucus production increase. Any activity
is a challenge. People with stage 4 COPD rely on oxygen therapy.
Flare-ups are increasingly serious, even possibly deadly.
2.3. Gait speed
Four-meter gait speed was assessed as a measure of exercise
capacity and frailty. A gait speed <0.8 m/s has been associated with
frailty [18,19]. The rolling-start 4 m gait speed was measured at the
patient’s usual pace in an unobstructed clinic hallway. Each walk
was performed with a 2 m rolling start, meaning each participant
was already walking as they entered the measuring area. Canes,
walkers and supplemental oxygen were used if the patient
normally utilized the equipment in daily activities. Two cones
were placed 8 m apart, with the automated Dual Beam Wireless
Infrared Timing System (TracTronix, Lenexa, KS) centered 2 m after
the ﬁrst cone and 2 m before the second cone. Patients were
instructed to “walk at their usual pace” from one cone to the other.
2.4. Questionnaires
SM was measured using the SMAS-30 [20]. In this validated
questionnaire, already used in COPD, six core SM abilities are
studied: taking initiatives (to be instrumental or self-motivating
with regard to the realization of dimensions of well-being);
investment behavior (to invest in resources for longer-term
beneﬁts); variety (to achieve and maintain various resources for
each dimension of well-being); multi-functionality (to gain and
maintain activities which serve multiple dimensions of well-being
at the same time in a mutually reinforcing way); self-efﬁcacy (to
gain and maintain a belief in personal competence to achieve well-l Framework.
Table 1
Cohort characteristics.
Mean (SD) or N (%)
n 292
Age(yrs) 70(9.46)
Gender
Male 177(61%)
BMI 28.2 (6.8)
Live alone (yes) 49 (23%)
Married 156 (75%)
Use of permanent oxygen 76 (37%)
Gait Speed (meters/second) 1.07 (0.22)
Breathlessness mMRC (scale 0–4) 2.00 (1.1)
PFT Data
FVC % 70.24 (17.4)
FEV1 % predicted 40.8 (17.9)
FEV1/FVC 47.8 (16.3)
DLCO % 52.5 (18.3)
Exacerbations 2 114 (40)
Hospital admission previous year 94 (33)
ADO index (range 0–14) 8.8 (2)
GOLD stages
A = mild 59 (20%)
B = moderate 46 (16%)
C = severe 53 (18%)
D = very severe 134 (46%)
Note: SD = standard deviation; BMI = body mass index; PFT = pulmonary function
test; ADO = age-dyspnea-obstruction index; GOLD = global initiative for obstructive
lung disease; mMRC = modiﬁed medical research council dyspnea score.
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perspective regarding the future, rather than to focus on loss)
[20]. The total score of the entire scale on a 100-point scale is
calculated from the average of the total scores of the six subscales
[20].
QoL was assessed using the chronic respiratory questionnaire
self-administered standardized format (CRQ-SAS). The CRQ-SAS is
a validated questionnaire to measure the health status of patients
with COPD. It has a total score (main outcome in this study) and
four sub-domains dyspnea, fatigue, emotional and mastery [21].
Scores are on a 1–7-point scale; the lower the score, the greater the
dysfunction [22]. A difference of 0.5 in any dimension is considered
clinically signiﬁcant.
Emotions were measured using the positive and negative affect
schedule (PANAS), a 20-item scale measuring the positive and
negative affective components of well-being [23].The scale
consists of 10 positive words and 10 negative words that describe
different feelings and emotions. Higher sum scores on each sub-
scale indicates more positive and more negative affect, respective-
ly on a 50-point scale [23]. We calculated the ratio of positive to
negative affect, known as the critical positivity ratio [24], which
claims to distinguish individuals that are emotionally balanced
from those who are not. Individuals with higher ratios were found
to have greater ﬂexibility and resilience to adversity, more social
resources, and better optimal functioning in many areas of their life
[24]. Researchers have long suggested that the balance of positive
to negative affect is critically relevant to well-being and adjust-
ment [25,26]. Recently, Larsen and Prizmic argued that the balance
of positive to negative affect (hereafter referred to as the critical
positivity ratio) is a key factor in subjective well-being and in
deﬁning whether a person ﬂourishes [27]. Larsen and Prizmic
discussed work by several authors [24,28–30] which suggests that
to maintain an optimal level of emotional well-being and positive
mental health, individuals need to experience approximately three
times more positive than negative affect.
2.4.1. Breathlessness (dyspnea mMRC)
The modiﬁed medical research council (mMRC) dyspnea scale is
a 5-item tool used to assess dyspnea in patients with COPD [31].
The mMRC is universally accepted tool to measure breathless ness
and used to classify COPD based disease burden in the most recent
global initiative for chronic obstructive lung disease (GOLD) global
strategy for the diagnosis, management, and prevention of COPD.
[32]
2.5. Statistical analysis
JMP statistical software (version 9.01, SAS, Cary, NC) was used
for all analyses. Correlation analyses were tested between the
measure variables. Univariate and multivariate models were built
to predict QoL (dependent variable) including all signiﬁcant
variables from the univariate analysis as independent variables.
We used bootstrapping methods (2000 iterations) to conﬁrm the
robustness of the models and to build a conﬁdence interval for the
Adjusted R square of the models. All tests were 2-sided and p-
values less than 0.05 were considered statistically signiﬁcant.
Descriptive analysis included calculating means and standard
deviations (SDs). The mediation effect of the critical positivity ratio
on the association between SM and QoL was evaluated based on
conditions put forth by Baron and Kenny [33,34] and Judd and
Kenny [35]. Condition 1: the theoretically speciﬁed independent
variables must emerge as signiﬁcant predictors of the outcome
variable (QoL) in correlation analyses. Condition 2: the theoreti-
cally speciﬁed independent variables must emerge as signiﬁcant
predictors of the mediator variable critical positivity ratio in
correlation analyses. Condition 3: the mediator variable must besigniﬁcantly associated with the outcome variable after controlling
for the independent variables. Condition 4: the relationship
between the signiﬁcant independent variables (SM) and the
outcome variable (QoL) must be signiﬁcantly reduced when the
effects of the mediator variable (critical positivity ratio) is included
in the model.
2.5.1. Sample size
Two hundred and eighty subjects with complete records was
calculated as the minimum required sample size for the proposed
study, a cross sectional study using a multiple regression model to
predict the effect of the desired variable to be studied—self
management and clinical positivity ratio- on the desired outcome
(disease speciﬁc quality of life), given a probability level of 0.05
(a = 0.05), anticipating 5 predictors in the model initially expected
to be at least age, degree of breathlessness (most common
symptom in COPD and degree of bronchial obstruction (fev1%),—
the latter are the most signiﬁcant and universally accepted
outcomes associated with COPD progress) with an the anticipated
effect size (a change in R square in the model) for the variable
studied >5%, and a statistical power level of 0.9.We anticipated a
level of missingness of 5%, so we aimed for at least 294 individuals
to be recruited.
3. Results
Baseline characteristics of the cohort are shown in Table 1.
Patients with COPD (n = 292) were included (61% male, mean age
70 years). The spirometric impairment was predominantly severe
(65% of the patients presented FEV1<50%). 40% of the patients
suffered an exacerbation of the disease the previous year and 33%
required a hospitalization for breathing problems. Patient reported
outcomes are shown in Table 2.
To study the construct of SMAS-30 in COPD, we included a
correlation analysis as shown in Fig. 2. The correlation analysis
Table 2
Patient reported outcomes.
Mean (SD) Min–Max score
CRQ Total 4.85 (1.13) 1–7
Dyspnea 5.03 (1.42) 1–7
Emotion 5.03 (1.17) 1–7
Mastery 5.23 (1.41) 1–7
Fatigue 4.09 (1.22) 1–7
SMAS-30 67.83 (11.55) 0–100
Taking initiatives 69.06 (16.90) 0–100
Investment
behavior
63.14 (17.83) 0–100
Self-efﬁcacy 87.00 (11.38) 0–100
Variety 46.65 (17.20) 0–100
Positive frame of
mind
69.63 (16.80) 0–100
Multifunctionality 68.52(13.49) 0–100
PANAS
Positive 33.04 (7.62) 10–50 higher scores representing higher
levels of positive affect
Negative 16.06 (6.42) 10–50 lower scores representing lower
levels of negative affect
Positive/negative
ratio
2.31 (1.02) 0.2–5
Notes: SD = standard deviation; CRQ = chronic respiratory questionnaire; SMAS
30 = self-management ability scale 30; PANAS = positive and negative affect
schedule.
Table 3
Correlation Matrix.
1. 2. 3. 4. 5. 6.
1. Age
2. mMRC 0.020
3. CRQ Total 0.209 0.502**
4. SMAS Total 0.150 0.210* 0.459**
5. Positivity Ratio 0.219 0.183 0.654*** 0.670***
6. BMI 0.008 0.214 0.236* 0.212 0.234
7.FEV1% Predicted 0.105 0.289* 0.177 -0.078 0.029 0.040
Notes: mMRC = modiﬁed medical research council dyspnea scale; CRQ = chronic
respiratory questionnaire; SMAS = self-management abilities scale; positivity
ratio = PANAS positive/negative affect ratio; BMI = body mass index; FEV1%
predicted = forced expiratory volume/forced vital capacity.
* p < 0.05.
** p < 0.001.
*** p < 0.0001.
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function but signiﬁcantly correlated with affect (directly with
positive affect and inversely with negative affect), gait speed and
QoL.
Univariate models to predict QoL (CRQ total) -not shown-
indicated that CRQ total score was signiﬁcantly associated with
age, COPD related hospitalization in the past year, being married,
BMI, living alone, breathlessness (mMRC dyspnea scale), lung
function, SM abilities, and the critical positivity ratio. Those
variables were then included into the multivariate models. Non-
signiﬁcant variables were then not included neither in the
correlation matrix nor in the multivariate models. Table 3
(correlation matrix) included continuos variables signiﬁcant in
the univariate model.Fig. 2. Correlation coefﬁcients between self-maOur results met conditions 1 and 2 for the mediation analysis as
shown by the correlations of independent variables with disease
speciﬁc quality of life (CRQ total) as displayed in Table 3. The results
indicated that CRQ total was signiﬁcantly and directly associated
with self-management abilities (SMAS), and the clinical positivity
ratio and inversely and signiﬁcantly associated with breathlessness
and BMI.
In multiple regression analyses using the mediating variable
(clinical positivity ratio) as the dependent variable and after
controlling for univariate signiﬁcant variables, the results indicat-
ed that CRQ (outcome variable) was signiﬁcantly related to clinical
positivity ratio.
Multiple regression analyses were performed to test conditions
3 and 4 for mediation as shown in Table 4 that present the direct
effects of Breathlessness (dyspnea m MRC) self-management
ability SMAS-30, marital status, age, living alone, bronchial
obstruction (FEV1%, the lower the number the worst) and history
of hospitalization on that outcome variable CRQ total score
(disease speciﬁc well-being). After controlling for all independent
variables, clinical positivity ratio was signiﬁcantly associated with
well-being-CRQ total- (b = 0.61) thus meeting condition 3 for
mediation.
In step 1 of the regression dyspnea (b = 0.35); self-management
abilities (b = 0.03); p B = 0.001), age (b = 0.01) and a history of a
COPD hospitalization in the last year (b = 0.18) signiﬁcantlynagement (SMAS-30) and COPD outcomes.
Table 4
Multiple regression analysis predicting Quality of Life in COPD and the mediating
effect of the clinical positivity ratio (Step 2).
Step 1
Rsq = 0.41
(CI 0.37-0.48#)
Step 2
Rsq = 0.60
(CI 0.56-0.71#)
Independent variable b b
Dyspnea mMRC 0.35** 0.31**
SMAS-30 0.03** 0.002
Married 0.17 0.19
Age 0.01* 0.01
Live alone 0.13 0.04
FEV1% 0.004 0.005
Hospitalized for COPD in past year 0.18* 0.14*
Clinical positivity ratio Not in model 0.61**
Notes: mMRC = modiﬁed medical research council dyspnea scale; critical positivity
ratio = PANAS positive/negative affect. QoL = quality of life; relationship examined
through chronic respiratory questionnaire total score. (#: conﬁdence interval of the
adjusted R square after 2000 bootstrapped models).
* p < 0.01.
** p < 0.001.
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relationship between the SMAS and the outcome variable CRQ
(well-being) must be signiﬁcantly reduced when the effects of the
mediator (clinical positivity ration) are included in the model.
Thus, clinical positivity ratio was included in step 2 of the
regression analysis. Self-management abilities lost signiﬁcance
related to well-being (b = 0.002) indicating the complete mediat-
ing effect of the clinical positivity ratio between self-management
abilities and quality of life in COPD. Furthermore, the age effect on
wellbeing was also lost in step 2 indicating also a complete
mediating effect by the clinical positivity ratio.
In summary Table 4 Step 1 (R square = 0.41) SM is independently
associated to QoL, after adjusting for FEV1% predicted, age,
hospitalizations. In Step 2, when we added the ratio of critical
positivity ratio to the model, not only the adjusted R square
signiﬁcantly improved to 0.60 but also the association between SM
and QoL lost signiﬁcance, completely meditated by the critical
positivity ratio
We further investigated the differences QoL and SM values
using the proposed cutoff of 2.9 for the positive/negative affect
ratio (the values of QoL and SMAS in subjects with a clinical
positivity ration below 2.9 and above 2,9) and found a statistically
and clinically signiﬁcant difference: 0.9 points (p = 0.0001) for CRQ
total (minimally clinically important difference is 0.5 points) and
for SMAS total score 12-point difference (p = 0.0001) which is
higher than one standard deviation difference which can be
considered a clinically signiﬁcant difference.
Lastly we explore which domains of SMAS were independently
associated with QoL (CRQ SAS) after adjusting for the univariate
signiﬁcant variables and found that only the domains Investment
Behaviors (b = 0.01, p < 0.05) and Self-efﬁcacy (b = 0.02, p < 0.05)
were the only ones signiﬁcant in this large cohort of COPD patients
explaining 14 and 13%, respectively of the overall variance of the
model and conﬁrmed by bootstrap analysis.
4. Discussion and conclusion
4.1. Discussion
We found that SM measured by the SMAS-30 was signiﬁcantly
and independently associated with disease speciﬁc QoL in COPD,
conﬁrming previous reports [4,5]. The novelty of our results relates
to the fact that that association of SM abilities with QoL is totally
mediated by the critical positivity ratio or the degree of positivity
of the individual.The SMAS-30 domains of investment behavior and self-efﬁcacy
were the only two domains that were independently associated
with COPD disease speciﬁc QoL. Our work extends previous reports
by Cramm et al. [10] by conﬁrming the association between SMAS-
30 and well-being in a much more characterized cohort of COPD
patients. We measured lung function, gait speed, disease speciﬁc
QoL, and positive and negative affect in addition to demographics
and background measures.
The association of SM and QoL (CRQ SAS total) is not affected by
lung function or living condition, and is minimally affected by age
suggesting that increasing age and more limited functional lung
capacity does not necessarily affect SM abilities. While SMAS-
30 measures a wide range of SM abilities; we found that the
domains of self-efﬁcacy and investment behavior are the ones that
independently predict QoL in this cohort of well characterized
COPD patients. Lower levels of reported self-efﬁcacy in managing
breathing issues have been related to increases in anxiety and
depression and QoL impairment [36]. More speciﬁcally, the
knowledge and ability to continue to perform tasks and activities
that are valued by the individual was a strong indicator of self-
reported health status in COPD, even when physical functioning
and COPD speciﬁc factors were accounted for [37]. The domain of
investment behavior from SMAS-30 includes questions about the
individual’s interests on a regular basis (such as a hobbies),
physical exercise engagement to maintain ﬁtness, efforts made to
keep in good contact with acquaintances, as well as time and
attention devoted to signiﬁcant others. The latter can be very
informative in generating dialogue and formulating goals in self-
management like health coaching.
Previous research in COPD supports our ﬁndings regarding the
relevancy of these two domains: In a study by Katz et al., it was
found that the declining in doing valued life activities (like
hobbies) in COPD patients were associated with onset of
depression symptoms [38], a known contributor to poorer
treatment adherence and self-care [5]. Social exposure was
associated with lower levels of anxiety and depression [36], and
with improved coping strategies in disease management [39] and
when social support was lacking, individuals identiﬁed it as a
barrier to active SM of disease conditions [40].
The most signiﬁcant and novel ﬁnding of this report is the
direct mediating effect of the critical positivity ratio in the
association between SM and QoL. Positive affect demonstrated
the highest correlation and independent association with QoL,
after adjusting for age, breathlessness measures and degree of
bronchial obstruction (FEV1% predicted), and the addition in the
prediction model increased the explanation of variance of QoL to
60% (from 40% in the step 1 model without the critical positivity
ratio Table 4. The robustness of the model is suggested by the tight
conﬁdence interval of the R square after the 2000 iteration of the
model in the bootstrap analysis Table 4. The mediation model,
included very meaningful outcome variables for COPD make our
results very relevant to understanding SM in COPD. To our
knowledge, these are novel ﬁndings and may translate directly into
initiatives for the care of patients.
Positive affect has been shown to have an impact on SM abilities
and QoL in individuals living with chronic disease [41]. Positivity
and its implications have been studied broadly [42–44], particu-
larly its importance in mental health [45] and well-being [46].
Decreased positivity has shown to be related to higher incidents of
catastrophizing [47]. Positive affect reﬂects the extent a person
feels enthusiastic and active, so high positive affect is a state of high
energy, full concentration and pleasure engagement, whereas low
positive affect is characterized by sadness and lethargy [48]. A
previous study showed that positive attitudes could improve
mood, emotional and physical well-being in patients with a
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COPD [49].
The clinical implications of our ﬁndings are rooted in the fact
that positive affect can be fostered through training that may be
incorporated into SM programs when people are found to have a
low critical positivity ratio. The previously proposed threshold of
2.9 points in the clinical positivity ratio [24] may serve at least as a
reference in clinical daily care of patients with COPD to identify
people with low positivity (<2.9). We acknowledge the existing
controversies about the rigid validity of the cutpoint but having a
simple reference will help implementation. The value of measuring
and quickly understanding the measure may derive in salutary
consequences: increasing the awareness of clinicians and patients
and creating condition for dialogue on that matter and instituting
interventions that may increase positivity.
Speciﬁc tools that have been utilized to increase positive
experiences that could be part of support SM including the use of
afﬁrmations [48], journaling, gratefulness practice [50,mindful-
ness of emotions and thoughts and utilizing daily data logs [51].
Mindfulness has been shown to decrease catastrophizing [52,53]
that is well reported in COPD [54,55] in pain-related symptoms
[56,57]. Decreasing the rigidity of catastrophizing and working
towards more ﬂexible, positive thinking through the use of
concrete tools has proved effective. Not only have these techniques
been shown decrease negative thinking, but they also contribute to
increased self-efﬁcacy, regardless of disease characteristics.
Our results of the mediating effect of positive affect have been
suggested in other chronic states, such as chronic pain syndromes,
in which individuals need to cope with persistent and many times
“unﬁxable” symptoms, such as breathlessness in many patients
with COPD. Positive affect offers an “upward spiral” model that can
translate to resilience and promote active engagement in valued
goals that enhance SM [17]. In clinical studies, the association of
positive affect and chronic symptoms is dynamic, time variant, and
may be best considered in the context of its interacting role with
negative affect, like we present in this study (the critical positivity
ratio) [48].
4.1.1. Limitations
Our study has some limitations. First, causal relationships could
not be inferred, as the data collected were cross-sectional. While
we showed that SM is a predictor of disease speciﬁc QoL, we did
not investigate whether interventions aimed to enhance SM
abilities lead to improved QoL or if positive affect interventions
have an effect on QoL. Further research is necessary to establish
those causal relationships. Second, because of the cross-sectional
data, further validation in other cohorts is desirable, even though
the results were rooted in robust models conﬁrmed by the
bootstrapping analysis. The speciﬁc SM abilities found signiﬁcantly
related to QoL (investment behaviors and self-efﬁcacy) are not
universal to all outcomes in COPD may not translate to other
outcomes beyond QoL, such as decreasing hospitalizations.
4.2. Conclusions
SM ability, measured by the total score of SMAS-30 is
independently associated with disease speciﬁc quality of life after
adjusting with the most meaningful co-variates for COPD.
However that association is totally mediated by the critical
positivity ratio or degree of positivity of the individual. Our results
are of relevance in crafting and implementing SM programs for
patients with COPD. The SMAS-30 is related to meaningful
outcomes in COPD and represents a good tool to measure SM
abilities in this condition.4.3. Practice Implications
This study suggests that measuring the critical positivity ratio,
in patients with COPD is not only signiﬁcant because of increasing
awareness of the degree of positivity of the individual that impact
disease speciﬁc quality of life in COPD but also because may have
signiﬁcant implications on the effect of COPD SM programs. The
2.9 cutoff point of the critical positivity ratio may be a useful in
clinical practice to quickly assess positivity, to generate dialogue
about positivity and its beneﬁts and to propose interventions that
may improve positive affect. Mindfulness, Emotional Intelligence
and Gratitude training are potential interventions to increase the
clinical positivity ratio, promoting ﬂourishing in COPD patients.
Investment time in meaningful behaviors (for the individual)
and self-efﬁcacy are likely key ingredients in COPD SM programs.
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